B. Lynne Parshall serves as Executive at ISIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, B. Lynne Parshall has executed 408 insider transactions totaling $54.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 19, 2025 involved selling 5,000 shares valued at $323.6K.
B. Lynne Parshall currently holds 22,933 shares of ISIS PHARMACEUTICALS INC (ISIS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, B. Lynne Parshall has been a net seller of ISIS stock. They have purchased $3.0M and sold $51.2M worth of shares.
B. Lynne Parshall's most recent insider trade was on Nov 19, 2025, when they sold 5,000 shares at $64.73 per share.
Get notified when new Form 4 filings are submitted
| $71.74 |
| Discretionary |
| Sep 2, 2025 | IONS | $542.0K | Sale | 10,750 | $50.42 | Discretionary |
| Sep 2, 2025 | IONS | $476.3K | Sale | 9,250 | $51.49 | Discretionary |
| Aug 6, 2025 | IONS | $192.6K | Sale | 4,600 | $41.87 | Discretionary |
| Aug 6, 2025 | IONS | $17.1K | Sale | 400 | $42.63 | Discretionary |
| Jul 15, 2025 | IONS | $0 | Option Exercise | 4,079 | $N/A | Discretionary |
| Sep 9, 2024 | CYTK | $108.0K | Option Exercise | 5,000 | $21.61 | Planned |
| Sep 9, 2024 | CYTK | $274.6K | Sale | 5,000 | $54.92 | Planned |
| Aug 26, 2024 | CYTK | $108.0K | Option Exercise | 5,000 | $21.61 | Planned |
| Aug 26, 2024 | CYTK | $286.3K | Sale | 5,000 | $57.26 | Planned |
| Aug 12, 2024 | CYTK | $276.0K | Sale | 5,000 | $55.20 | Planned |
| Aug 12, 2024 | CYTK | $108.0K | Option Exercise | 5,000 | $21.61 | Planned |
| Jul 29, 2024 | CYTK | $299.2K | Sale | 5,000 | $59.84 | Planned |
| Jul 29, 2024 | CYTK | $108.0K | Option Exercise | 5,000 | $21.61 | Planned |
| Jul 15, 2024 | CYTK | $53.4K | Option Exercise | 5,000 | $10.68 | Planned |
| Jul 15, 2024 | CYTK | $279.1K | Sale | 5,000 | $55.82 | Planned |
| Jul 15, 2024 | IONS | $0 | Option Exercise | 4,677 | $N/A | Discretionary |
| Jun 17, 2024 | CYTK | $262.8K | Sale | 5,000 | $52.55 | Planned |
| Jun 17, 2024 | CYTK | $53.4K | Option Exercise | 5,000 | $10.68 | Planned |
| Jun 3, 2024 | CYTK | $243.2K | Sale | 5,000 | $48.64 | Planned |
| Jun 3, 2024 | CYTK | $53.4K | Option Exercise | 5,000 | $10.68 | Planned |
| May 15, 2024 | CYTK | $0 | Award | 5,600 | $N/A | Discretionary |
| Dec 28, 2023 | IONS | $2.1M | Sale | 42,525 | $50.19 | Planned |
| Dec 28, 2023 | IONS | $2.0M | Option Exercise | 42,525 | $47.34 | Planned |
| Dec 27, 2023 | IONS | $2.5M | Sale | 50,000 | $50.23 | Planned |
| Dec 27, 2023 | IONS | $2.4M | Option Exercise | 50,000 | $47.34 | Planned |
| Dec 26, 2023 | IONS | $1.2M | Option Exercise | 25,113 | $47.34 | Planned |
| Dec 26, 2023 | IONS | $1.3M | Sale | 25,113 | $51.46 | Planned |
| Sep 26, 2023 | IONS | $451.3K | Sale | 10,000 | $45.13 | Planned |